Application of dideoxynucleoside phosphoramidite monomer containing succinimide structure in recognition of mismatched bases
A deoxynucleoside phosphoramidite and succinamide technology, applied in the field of non-natural oligonucleotide applications, can solve the problem of high cost
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0048] The present invention obtains a modification reagent of a non-natural oligonucleotide, that is, a deoxythymidine-deoxythymidine phosphoramidite monomer containing a succinamide structure, the chemical structure of which is as follows:
[0049]
[0050] The synthetic route of this monomer is as follows:
[0051]
[0052] Specific steps:
[0053] (a) Dissolve 10mmol zivudodine in 50mL anhydrous pyridine, add 10-20mmol 4,4-dimethoxytriphenylchloromethane in 10mL pyridine solution at room temperature, stir at room temperature for 1-12h; the reaction solution is concentrated After removing the solvent, add 50mL tetrahydrofuran, 1mL water and 1mL triethylamine, react at 85°C for 1-8h under the protection of nitrogen, concentrate to remove the organic solvent; Wash with water and dry over anhydrous sodium sulfate; the crude product can be directly used in the next step;
[0054] Dissolve 10mmol of the above-prepared product 5-(4,4-methoxytriphenylmethyl ether)-3-amino-...
Embodiment 2
[0070] Use of deoxythymidine-deoxythymidine phosphoramidite monomers containing succinamide structure for DNA synthesis
[0071] The synthetic route is as follows:
[0072]
[0073] Specific steps:
[0074] (d) 800 mg of double thymidine reagent (deoxythymidine-deoxythymidine phosphonamidite monomer containing succinamide structure) was dissolved in 3 mL of anhydrous acetonitrile, and transferred to the end group modification position of ABI394 nucleic acid synthesizer under nitrogen protection in the reagent bottle. Input nucleic acid sequence: 5'-TTC CAC TTA CCA GAT TGA TT-3', perform synthesis on the order of 1 μmol;
[0075] (e) After the synthesis is completed, the solid phase carrier is taken out, dispersed in 1mL 5-32% methylammonia aqueous solution, heated at 55-75°C for 1-4h, centrifuged to remove insoluble matter, and the solution is concentrated to obtain the crude product; the target product is obtained by Separation by HPLC and characterization of structural...
Embodiment 3
[0080] Application of Double Thymidine Reagent Containing Succinamide Structure in Construction of Resistant Enzyme Cutting Artificial Nucleic Acid
[0081] 1. A synthetic method for modifying the 5' end of an artificial nucleic acid with a double thymidine reagent containing a succinamide structure
[0082]
[0083] 2. A synthetic method for modifying the 3' end of an artificial nucleic acid with a double thymidine reagent containing a succinamide structure
[0084]
[0085] A method for synthesizing an enzyme-resistant artificial nucleic acid, the specific steps of which are:
[0086] Step a: Dissolve 800 mg of the reagent in 3 ml of anhydrous acetonitrile, and transfer it to the terminal modification site reagent bottle of the ABI 394 nucleic acid synthesizer under nitrogen protection. Input nucleic acid sequence: 5'-TTC CAC TTA CCA GAT TGA TT-3', perform synthesis on the order of 1 μmol.
[0087] Step b: After the synthesis is completed, the solid phase carrier is ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com